drug

vorolanib

Phase 3updated 3mo ago

by $EYPT EyePoint, Inc.

Phase 3

community read0 votes

indications

Diabetic Macular Edema

all catalysts(0)

nothing on the calendar yet

Trials studying vorolanib

phase2Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancerterminatedn=11
phase2Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumorscompletedn=88

News(1)

Chutes & Ladders—Cue lines up new CMO and research head
Cue Biopharma is tapping in a new chief medical officer and head of R&D in Dominic Borie, M.D., Ph.D., a physician-scientist with over two decades of industry experience.
fiercebiotech · 25d ago

Data sources

ClinicalTrials.gov

last refreshed 50m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

vorolanib

Phase 3updated 3mo ago

by $EYPT EyePoint, Inc.

Phase 3

community read0 votes

indications

Diabetic Macular Edema

all catalysts(0)

nothing on the calendar yet

Trials studying vorolanib

phase2Vorolanib + Atezolizumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancerterminatedn=11
phase2Phase I/II Eval Safety & Prelim Activity Nivolumab Comb W/Vorolanib Pts W/Refractory Thoracic Tumorscompletedn=88

News(1)

Chutes & Ladders—Cue lines up new CMO and research head
Cue Biopharma is tapping in a new chief medical officer and head of R&D in Dominic Borie, M.D., Ph.D., a physician-scientist with over two decades of industry experience.
fiercebiotech · 25d ago

Data sources

ClinicalTrials.gov

last refreshed 50m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

vorolanib

indications

all catalysts(0)

Trials studying vorolanib

News(1)

Report a data issue

comments(0)

vorolanib

indications

all catalysts(0)

Trials studying vorolanib

News(1)

Report a data issue

comments(0)